APA

Chen X., Lv R., Zhang W., Yan Y., Li P., Dong W., Liu X., Liang E., Tian H., Lu Q. & Zhang M. (20180118). Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition. : Oncotarget.

Chicago

Chen Xue-Ying, Lv Rui-Juan, Zhang Wei, Yan Yu-Gang, Li Peng, Dong Wen-Qian, Liu Xue, Liang Er-Shun, Tian Hong-Liang, Lu Qing-Hua and Zhang Ming-Xiang. 20180118. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition. : Oncotarget.

Harvard

Chen X., Lv R., Zhang W., Yan Y., Li P., Dong W., Liu X., Liang E., Tian H., Lu Q. and Zhang M. (20180118). Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition. : Oncotarget.

MLA

Chen Xue-Ying, Lv Rui-Juan, Zhang Wei, Yan Yu-Gang, Li Peng, Dong Wen-Qian, Liu Xue, Liang Er-Shun, Tian Hong-Liang, Lu Qing-Hua and Zhang Ming-Xiang. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition. : Oncotarget. 20180118.